New Derivatives of Lupeol and Their Biological Activity

Molbank ◽  
10.3390/m1306 ◽  
2021 ◽  
Vol 2021 (4) ◽  
pp. M1306
Author(s):  
Hoang-Thuy-Tien Le ◽  
Quoc-Cuong Chau ◽  
Thuc-Huy Duong ◽  
Quyen-Thien-Phuc Tran ◽  
Nguyen-Kim-Tuyen Pham ◽  
...  

The natural product lupeol (1) was isolated from Bombax ceiba leaves, which were used as starting material in the semisynthetic approach. Three new derivatives (2a, 2b, and 3) were synthesized using oxidation and aldolization. Their chemical structures were elucidated by spectroscopic analyses (HRESIMS and NMR). Compounds 3 showed significant α-glucosidase inhibition with an IC50 value of 202 µM, whereas 2a and 2b were inactive.

Molecules ◽  
2019 ◽  
Vol 24 (20) ◽  
pp. 3697 ◽  
Author(s):  
Monivan Chhour ◽  
Agnès Aubouy ◽  
Sandra Bourgeade-Delmas ◽  
Pierre Pério ◽  
Hélène Ternet-Fontebasso ◽  
...  

Dunnione, a natural product isolated from the leaves of Streptocarpus dunnii (Gesneriaceae), acts as a substrate for quinone-reductases that may be associated with its antimalarial properties. Following our exploration of reactive oxygen species-producing compounds such as indolones, as possible new approaches for the research of new ways to treat this parasitosis, we explored derivatives of this natural product and their possible antiplasmodial and antimalarial properties, in vitro and in vivo, respectively. Apart from one compound, all the products tested had weak to moderate antiplasmodial activities, the best IC50 value being equal to 0.58 µM. In vivo activities in the murine model were moderate (at a dose of 50 mg/kg/mice, five times higher than the dose of chloroquine). These results encourage further pharmacomodulation steps to improve the targeting of the parasitized red blood cells and antimalarial activities.


2021 ◽  
Author(s):  
◽  
Ashton Nikylla Asbury

<p>Rimarikiamide A is a linear diterpenoid marine natural product featuring an unusual taurine structural moiety. Rimarikiamide A was isolated from the sea sponge Latrunculia brevis found in the Rimariki Islands in northern New Zealand, and was shown to elicit low μM cytotoxicity against HL-60 cells. Unfortunately, only 400 μg of rimarikiamide A was isolated from 700 g of sea sponge, making the characterisation of the two chiral centres impossible by spectroscopic means. To explore the full potential of rimarikiamide A as a therapeutic agent, the molecule must be synthesised in a stereoselective manner or from a starting material of known stereochemistry, fully characterised, and tested for biological activity. A Barbier coupling of two terpene units is required early in the proposed synthesis of Rimarikiamide A, and previous attempts have failed to generate the desired linear product. In this work, the suitability of a titanium-mediated Barbier coupling was investigated, and proved successful for the generation of the desired linear product.</p>


Marine Drugs ◽  
2019 ◽  
Vol 17 (7) ◽  
pp. 384 ◽  
Author(s):  
Qinxue Jing ◽  
Xu Hu ◽  
Yanzi Ma ◽  
Jiahui Mu ◽  
Weiwei Liu ◽  
...  

Marine natural products are considered to be valuable resources that are furnished with diverse chemical structures and various bioactivities. To date, there are seven compounds derived from marine natural products which have been approved as therapeutic drugs by the U.S. Food and Drug Administration. Numerous bromotyrosine derivatives have been isolated as a type of marine natural products. Among them, psammaplin A, including the oxime groups and carbon–sulfur bonds, was the first identified symmetrical bromotyrosine-derived disulfide dimer. It has been found to have a broad bioactive spectrum, especially in terms of antimicrobial and antiproliferative activities. The highest potential indole-derived psammaplin A derivative, UVI5008, is used as an epigenetic modulator with multiple enzyme inhibitory activities. Inspired by these reasons, psammaplin A has gradually become a research focus for pharmacologists and chemists. To the best of our knowledge, there is no systematic review about the biological activity and structural modification of psammaplin A. In this review, the pharmacological effects, total synthesis, and synthesized derivatives of psammaplin A are summarized.


2013 ◽  
Vol 68 (4) ◽  
pp. 383-390 ◽  

Thirteen 1-deoxynojirimycin (DNJ) derivatives of five different skeletal structures were designed and synthesized. The newly synthesized compounds were evaluated using an in vitro a- glucosidase assay, and kinetic parameters (Ki, IC50) were measured. Some DNJ derivatives showed weak a-glucosidase inhibitory activities, and the compounds 1-(3-benzyloxy-2-hydroxypropyl)- 2-hydroxymethyl-piperidine-3,4,5-triol (2a) and 1-{3-[1-(4-fluorophenyl)-1H-[1,2,3]triazol-4-ylmethoxy]- 2-hydroxypropyl}-2-hydroxymethyl-piperidine-3,4,5-triol (13d) showed activities comparable to that of DNJ. While 2a was found to be a reversible, non-competitive inhibitor of a-glucosidase with a Ki value of 1.56X10-4 M and an IC50 value of 3.07X10x4 M, 13d was a reversible, competitive inhibitor of a-glucosidase with a Ki value of 2.08X10-4 M and an IC50 value of 3.31X10-4 M.


2021 ◽  
Author(s):  
◽  
Ashton Nikylla Asbury

<p>Rimarikiamide A is a linear diterpenoid marine natural product featuring an unusual taurine structural moiety. Rimarikiamide A was isolated from the sea sponge Latrunculia brevis found in the Rimariki Islands in northern New Zealand, and was shown to elicit low μM cytotoxicity against HL-60 cells. Unfortunately, only 400 μg of rimarikiamide A was isolated from 700 g of sea sponge, making the characterisation of the two chiral centres impossible by spectroscopic means. To explore the full potential of rimarikiamide A as a therapeutic agent, the molecule must be synthesised in a stereoselective manner or from a starting material of known stereochemistry, fully characterised, and tested for biological activity. A Barbier coupling of two terpene units is required early in the proposed synthesis of Rimarikiamide A, and previous attempts have failed to generate the desired linear product. In this work, the suitability of a titanium-mediated Barbier coupling was investigated, and proved successful for the generation of the desired linear product.</p>


Molecules ◽  
2019 ◽  
Vol 24 (3) ◽  
pp. 489 ◽  
Author(s):  
Hong Li ◽  
Seo Yang ◽  
Young Kim ◽  
Wei Li

Two new phenolic glucosides, pipercroside A and B (1 and 2), along with 10 known compounds were isolated from the leaves of Piper crocatum Ruiz & Pav. Their chemical structures were elucidated through extensive spectroscopic analyses, including 1D and 2D NMR experiments and HR-ESI-MS analysis and comparison with previously reported data. All the isolated compounds were assessed for soluble epoxide hydrolase (sEH) inhibitory activity. Among them, erigeside II (5) showed inhibitory activity with an IC50 value of 58.5 µM.


Planta Medica ◽  
2016 ◽  
Vol 81 (S 01) ◽  
pp. S1-S381
Author(s):  
P Terrazas ◽  
O Sterner

2018 ◽  
Author(s):  
William A. Shirley ◽  
Brian P. Kelley ◽  
Yohann Potier ◽  
John H. Koschwanez ◽  
Robert Bruccoleri ◽  
...  

This pre-print explores ensemble modeling of natural product targets to match chemical structures to precursors found in large open-source gene cluster repository antiSMASH. Commentary on method, effectiveness, and limitations are enclosed. All structures are public domain molecules and have been reviewed for release.


2020 ◽  
Vol 20 (5) ◽  
pp. 396-407 ◽  
Author(s):  
Zhaojun Sheng ◽  
Siyuan Ge ◽  
Min Gao ◽  
Rongchao Jian ◽  
Xiaole Chen ◽  
...  

Embelin is a naturally occurring para-benzoquinone isolated from Embelia ribes (Burm. f.) of the Myrsinaceae family, and contains two carbonyl groups, a methine group and two hydroxyl groups. With embelin as the lead compound, more than one hundred derivatives have been reported. Embelin is well known for its ability to antagonize the X-linked inhibitor of apoptosis protein (XIAP) with an IC50 value of 4.1 μM. The potential of embelin and its derivatives in the treatment of various cancers has been extensively studied. In addition, these compounds display a variety of other biological effects: antimicrobial, antioxidant, analgesic, anti-inflammatory, anxiolytic and antifertility activity. This paper reviews the recent progress in the synthesis and biological activity of embelin and its derivatives. Their cellular mechanisms of action and prospects in the research and development of new drugs are also discussed.


Sign in / Sign up

Export Citation Format

Share Document